Influenza A MP (58-66) Peptide (GILGFVFTL)

Antigen Peptide Flu M1 58-66 is an immunodominant epitope derived from the Influenza A matrix protein (MP), ideal for immunological research and T-cell stimulation. This specific epitope, GILGFVFTL, is restricted by the HLA-A*02:01 allele and recognized as a key target in influenza immune responses. This Influenza MP (58-66) peptide is highly suitable for a range of immunological assays, particularly those targeting CD8+ T cells.

Influenza A MP (58-66) Peptide (GILGFVFTL) - AA 58-66 for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Influenza A MP (58-66) Peptide (GILGFVFTL) - Specifications

Key Applications of Influenza A MP (58-66) - CAS: 141368-69-6

The Influenza A MP (58-66) peptide is a valuable tool in immune research, offering robust applications such as:

• CD8+ T-Cell Stimulation: Used in T-cell assays including ELISPOT, ICS, cytotoxicity, and proliferation assays.
• Antigen Loading: Compatible with dextramers/tetramers for antibody production.
• Research and Development: Assists in mapping T cell epitopes, immune monitoring, and vaccine development.

Benefits of JPT's Influenza Antigen Peptides

Our JPT Peptide Technologies antigen peptides are manufactured with the highest quality standards, supported by long-standing expertise in peptide synthesis. Key advantages include:


• Precision in Synthesis: All peptides are synthesized in Germany, with protocols designed to eliminate toxic contaminants and side products.

• Customized Orders: Choose your peptide sequence, amount, and purity, with options for bulk orders and custom synthesis.

• Stability and Quality Assurance: Each peptide undergoes HPLC-MS analysis for confirmation of purity and quality, and is provided as freeze-dried aliquots to enhance stability.

• Clinical Research Ready: Proven record in clinical study applications.


Choose Your Custom Peptides for Influenza and More

At JPT, we support researchers by offering an extensive catalog of antigen peptides. Find your desired antigen peptide along with connected PepMix™ Peptide Pools and MHC Multimers. These tools enable efficient immune monitoring, T-cell epitope mapping, and development of immunotherapies and vaccines.

Why Choose Influenza A MP (58-66) for Immune Research?

The Flu M1 (58-66) peptide plays a critical role in immune research targeting the influenza virus. Leveraging this peptide in T-cell assays and other immunological applications enhances the accuracy of epitope mapping and immune response studies. Researchers can rely on JPT Peptide Technologies to supply high-quality peptides that meet rigorous standards for use in both pre-clinical and clinical research settings.

For more Peptide Tools to Study Influenza or to learn about our range of custom antigen peptides, visit our website. Let us assist you in selecting and synthesizing the right peptides for your research needs.